(Q42199329)

18 October 2017

0 references

Are antithyroid drugs immunosuppressive? (English)

1 reference

18 October 2017

Kendall-Taylor P

1

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 February 1984

1 reference

18 October 2017

1 reference

18 October 2017

288

1 reference

18 October 2017

6416

1 reference

18 October 2017

509-511

1 reference

Hyperthyroidism in the land of Graves: results of treatment by surgery, radio-iodine and carbimazole in 837 cases.

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Specificity of the immunosuppressive action of carbimazole in Graves's disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Comparison of Effects of High and Low Dosage Regimens of Antithyroid Drugs in the Management of Graves’ Hyperthyroidism*

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

HLA-DR3 and HLA-DR5 Associated Thyrotoxicosis-Two Different Types of Toxic Diffuse Goiter*

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Thyroid Peroxidase and Thyroxine Biosynthesis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Long-term Antithyroid Treatment in Hyperthyroidism

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Short-Term Antithyroid Drug Therapy for the Thyrotoxicosis of Graves's Disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Lymphoid tissue in the thyroid gland and thymus of patients with primary thyrotoxicosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Quantitative radiological and histological studies of the thymus in thyroid disease.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Influence of iodine intake after treatment with antithyroid drugs.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Remission of thyrotoxicosis during treatment with propranolol.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Mode of action of carbimazole in Graves' disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Sequential assessment during drug treatment of thyrotoxicosis.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Inhibition of Immunoglobulin-Secreting Cells by Antithyroid Drugs*

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1444587

Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies

17 August 2018

1 reference

12 December 2020

Clinical response to long-term propranolol therapy in hyperthyroidism

1 reference

12 December 2020

Thyroid suppressibility: follow-up for two years after antithyroid treatment

1 reference

12 December 2020

Low remission after therapy for Graves disease. Possible relation of dietary iodine with antithyroid therapy results

1 reference

12 December 2020

Single-dose, "Block-Replace" Drug Therapy in Hyperthyroidism

1 reference

12 December 2020

Studies of thyroid function using 99Tcm in thyrotoxic patients during treatment with antithyroid drugs

1 reference

12 December 2020

The in vitro suppression of lectin induced 3H-thymidine incorporation into DNA of peripheral blood lymphocytes after the addition of propylthiouracil

1 reference

12 December 2020

1 reference

12 December 2020

Changes in Thyroid-Stimulating Immunoglobulins during Antithyroid Therapy*

1 reference

12 December 2020

Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study

1 reference

12 December 2020

Prediction of relapse in hyperthyroid Graves' disease

1 reference

12 December 2020

Carbimazole and the Autoimmune Response in Graves' Disease

1 reference

12 December 2020

Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease

1 reference

12 December 2020

Suppressor T lymphocyte dysfunction in Graves' disease: role of the H-2 histamine receptor-bearing suppressor T lymphocytes

1 reference

12 December 2020

Follow-Up Comparison of Short-TermVersus1-Year Antithyroid Drug Therapy for the Thyrotoxicosis of Graves' Disease*

1 reference

12 December 2020

The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat

1 reference

12 December 2020

Intrathyroidal concentrations of methimazole in patients with Graves' disease

1 reference

12 December 2020

Methimazole inhibits thyroid autoantibody production by an action on accessory cells

1 reference

12 December 2020

Outcome of patients with Graves' disease after long-term medical treatment guided by triiodothyronine (T3) suppression test

1 reference

12 December 2020

Long-term outcome of hyperthyroidism treated with antithyroid drugs

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.288.6416.509

0 references

1 reference

18 October 2017

PubMed publication ID

6199072

1 reference